Nadav Mortman


Nadav Mortman
BS, Biochemistry
Boston College
Chestnut Hill, MA
MS, Biomedical Sciences
Tufts University School of Medicine
Boston, MA
Research Technician
Ralph Isberg, PhD, Adviser



Acinetobacter baumanii, an opportunistic pathogen, is a danger to hospitalized patients around the world. Our aim is to discover genes that, when made nonfunctional, increase A. baumanii’s susceptibility to antibiotics. We are using a powerful genetic approach called Tn-seq, which allows us to study the role of almost every gene in the bacterium in contributing to drug resistance. Identified genes of interest will be studied for their ability to help clear Acinetobacter infections in culture and in animals. These genes have the potential to become novel drug targets.

Back to the Isberg Profile Page

Apply to the Sackler School


The priority application deadlines are as follows:

December 1: Basic Science Division PhD Programs

February 15: Building Diversity in Biomedical Sciences

March 31: Post-Baccalaureate Research Program

May 1: Clinical & Translational Science, MS in Pharmacology & Drug Development

June 15: Online Certificate in Fundamentals of Clinical Care Research